Sageworth Trust’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-46
Closed -$6.13K – 77
2023
Q1
$6.13K Hold
46
– – ﹤0.01% 350
2022
Q4
$4K Hold
46
– – ﹤0.01% 264
2022
Q3
$3K Hold
46
– – ﹤0.01% 280
2022
Q2
$3K Hold
46
– – ﹤0.01% 312
2022
Q1
$3K Hold
46
– – ﹤0.01% 284
2021
Q4
$3K Sell
46
-154
-77% -$9.12K ﹤0.01% 481
2021
Q3
$9K Hold
200
– – ﹤0.01% 569
2021
Q2
$8K Buy
+200
New +$8.29K ﹤0.01% 628

Other funds holding ACLS

Sageworth Trust's ACLS Position: Q2 2023 in Review

Sageworth Trust sold out of Axcelis (ACLS) in Q2 2023, closing a stake of 46 shares — an estimated $6.13K sold.

Sageworth Trust first reported a position in ACLS in Q2 2021 and held it in 8 quarters. The position peaked at $9K in Q3 2021. 405 funds tracked by Wall St. Rank hold ACLS as of Q2 2023.

  • Sageworth Trust reported no remaining Axcelis position as of Q2 2023 after selling out during the quarter.
  • Sageworth Trust sold 46 Axcelis shares in Q2 2023, an estimated $6.13K.
  • Sageworth Trust first reported a position in Axcelis in Q2 2021 and held it in 8 quarters.
  • Sageworth Trust's Axcelis position peaked at $9K in Q3 2021.
  • 405 funds tracked by Wall St. Rank held Axcelis as of Q2 2023.

Based on Sageworth Trust's 13F filing for Q2 2023, filed 26 Jul 2023.